Medroxyprogesterone acetate
National NHS prescribing (Prescription Cost Analysis) · Sex hormones and hormone antagonists in malignant disease
Medroxyprogesterone acetate was ranked 834th of 1,794 medicines by items in March 2026, with 1,438 items, up 9.5% on a year earlier.
1,438items
Dispensed in March 2026
NHSBSA Prescription Cost Analysis
£60,381
Net ingredient cost · March 2026
NHSBSA PCA
17,148items
Dispensed in the last 12 months
NHSBSA PCA
Figure 1. Medroxyprogesterone acetate: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to March 2026
Embed this chart
Top presentations, March 2026
The individual products dispensed under Medroxyprogesterone acetate, by items this month.
| Presentation | Items | Net ingredient cost |
|---|---|---|
| Medroxyprogesterone 100mg tablets | 653 | £22,422 |
| Medroxyprogesterone 200mg tablets | 578 | £25,905 |
| Medroxyprogesterone 400mg tablets | 149 | £9,800 |
| Provera 100mg tablets | 51 | £1,679 |
| Provera 200mg tablets | 6 | £399 |
| Provera 400mg tablets | 1 | £176 |
Compare Medroxyprogesterone acetate with
Other medicines in the same BNF section, by prescribing volume.